Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03329001
Title Crossover Study to Assess the Relative Bioavailability of Niraparib Tablet Compared to Niraparib Capsule
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Encinitas California 92024 United States Details
GSK Investigational Site Fresno California 93720 United States Details
GSK Investigational Site Denver Colorado 80218 United States Details
GSK Investigational Site New Haven Connecticut 06520 United States Details
GSK Investigational Site Sarasota Florida 34232 United States Details
GSK Investigational Site Atlanta Georgia 30322 United States Details
GSK Investigational Site Grand Rapids Michigan 49546 United States Details
GSK Investigational Site Jackson Mississippi 39216 United States Details
GSK Investigational Site Cincinnati Ohio 45267 United States Details
GSK Investigational Site Cleveland Ohio 44106 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site San Marcos Texas 92069 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field